2023 – BELNUC Seminar at SCK CEN in Mol 
BELNUC Seminar at SCK CEN in Mol
This BELNUC seminar has been granted three credits in Ethics & Economy by RIZIV/INAMI!
- Address: Boeretang 201, 2400 Mol
- Date: December 2, 2023
| 09:00 | Arrival @ SCK CEN |
| 09:05 | SCK CEN access control Transfer to building GKD |
| 09:30 | Research & Development in Nuclear Medical Applications @ SCK CEN (Lab visits) |
| 10:30 | End of visit – transfer to Lakehouse |
| 11:00 | Coffee break |
| 11:30 | Scientific presentation 1 Koen Hasaers | Scientific Advances in Nuclear Medical Applications for Cancer Therapy |
| 12:00 | Scientific presentation 2 Sven Van den Berghe | PanTera: Actinium-225 to treat cancer |
| 12:30 | Wrap-up |
Programme Group 2
| 09:00 | Arrival @ Lakehouse |
| 09:15 | Scientific presentation 1 Koen Hasaers | Scientific Advances in Nuclear Medical Applications for Cancer Therapy |
| 09:45 | Scientific presentation 2 Sven Van den Berghe | PanTera: Actinium-225 to treat cancer |
| 10:15 | Coffee break |
| 10:45 | Transfer to building GKD |
| 11:00 | SCK CEN access control |
| 11:30 | Research & Development in Nuclear Medical Applications @ SCK CEN (Lab visits) |
| 12:30 | End of visit – Wrap-up |
Check out the speakers
 |
Koen Hasaers is the Director of the Institute of Nuclear Medical Applications at SCK CEN, a pioneering institute for nuclear medicine and cancer therapy research including around 100 accomplished scientists and other supporting staff members. With cutting-edge research, cross-disciplinary expertise, and state-of-the art facilities, his institute propels innovation in radiopharmaceutical research & development, cancer treatment, and radioisotope production. K. Hasaers’ extensive experience spans complex markets, where he excels as a business developer and product innovator. His international supply chain skills extend across Europe, the US, China, and emerging markets. As a governance specialist, he has chaired the board and successfully secured funding from major Venture Capital funds. His academic background includes MSc degrees in Bioengineering, Engineering and Automation from Gent University, Belgium.
|
 |
Sven Van den Berghe is a master of physics graduate of the University of Ghent with a PhD in materials science from the University of Limoges in France, in collaboration with the Institute for Transuranic Elements in Germany and the Belgian nuclear research centre SCK-CEN. He has held the position of head of the Microstructural and Nondestructive Analysis laboratory at the SCK CEN Hotlab for 15 years before becoming the BR2 reactor stakeholder manager. In 2018, he was appointed as the director of the Nuclear Materials Science institute of the SCK CEN, which hosts the BR2 reactor and the hot laboratories. For over 20 years, he has been researching novel research reactor fuels and is regarded as an international fuel development expert while also leading internal and external low-enriched uranium fuel conversion projects. He is currently appointed as the BR2 LEU Conversion Stakeholder Manager.
In 2022 Sven has been appointed CEO For PanTera, a spin-off between SCK CEN and IBA to develop, design and build a production facility for Ac-225 in the battle against cancer. The motivation to take up this position in leading a new company is the idea that the products PanTera will create will signify new hope for cancer patients around the world. |
How to get to SCK CEN in Mol?
The address is “Boeretang 200, 2400 Mol”. Two neighbouring streets – Boeretang and Lichtstraat – are only accessible to employees of SCK CEN, VITO and Belgoprocess. If you want to get there easily, we recommend you enter the crossing between “Gravenstraat” and “Boeretang” in your GPS.
The visit starts at the SCK CEN Lakehouse. So, make a right turn before the main entrance and follow the “Lakehouse” sign. Enough parking spots are also provided.
